Repare Therapeutics Inc (RPTX) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.96x

Repare Therapeutics Inc (RPTX) has a Cash Flow Reinvestment Rate of 0.96x as of September 2025, reinvesting $2.54 Million (capex $0.00 plus investments $2.54 Million) from operating cash flow of $2.65 Million. Check cash flow quality index of Repare Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.96x
(Capex + Investments) / Operating CF

Total Reinvested

$2.54 Million
Capex + Investments

Operating Cash Flow

$2.65 Million
USD

Capital Expenditures

$0.00
USD

Repare Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)

Historical reinvestment intensity for Repare Therapeutics Inc across 1 annual periods. Explore Repare Therapeutics Inc (RPTX) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Repare Therapeutics Inc (2022–2022)

Year-by-year capital reinvestment analysis for Repare Therapeutics Inc. For live market cap and broader valuation context, see market cap of Repare Therapeutics Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2022 547.76x $176.38 Million $322.00K $602.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow